undefined undefined
NaN.000
NaN.00%
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on TYRA st...
05-13 15:16
Tyra Biosciences press release (NASDAQ:TYRA): Q1 GAAP EPS of -$0.35 beats by $0.11. As of March 31, 2024, TYRA had cash, cash equivalents, and marketable securities of $382.5 million. The company's cu...
05-10 20:17
An announcement from Tyra Bioscience (TYRA) is now available. Tyra Biosciences,...
05-08 04:45
CARLSBAD, Calif., May 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that tar...
05-08 04:05
CARLSBAD, Calif., Feb. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that ta...
02-08 05:05
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded up 0.49% to 38,705.29 while the NASDAQ rose 1.81% to 15,639.81. The S&P 500 also rose, gaining, 1.20% to 4,965.03.
02-03 03:32
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 0.19% to 38,593.49 while the NASDAQ rose 1.55% to 15,600.39. The S&P 500 also rose, gaining, 0.97% to 4,953.70.
02-03 01:08
- Enrollment and dose escalation ongoing in SURF301 Phase 1/2 oncology - - Presented additional preclinical data on TYRA-300 in achondroplasia at ASBMR and ASHG - - First patient to be dosed...
2023-11-08 05:05